Cumberland Pharmaceuticals (CPIX) Times Interest Earned (2010 - 2026)
Cumberland Pharmaceuticals' (CPIX) quarterly Times Interest Earned came in at -$36.46 in Q1 2026, down 562.21% year-on-year from $7.89 in Q1 2025, and down 200.27% quarter-over-quarter from -$12.14 in Q4 2025.
Cumberland Pharmaceuticals (CPIX) Times Interest Earned (2010 - 2026) Analysis & Trends
Cumberland Pharmaceuticals has disclosed Times Interest Earned across 17 years of filings, most recently posting -$36.46 for Q1 2026.
- Times Interest Earned for Q1 2026 came in at -$36.46, down 562.21% year-over-year; the trailing twelve-month figure through Mar 2026 was -$17.26 (down 243.28% YoY), and the FY2025 annual result was -$5.63, up 47.01% from the prior year.
- Times Interest Earned came in at -$36.46 for Q1 2026 at Cumberland Pharmaceuticals, down from -$12.14 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $7.89 in Q1 2025 to a low of -$36.46 in Q1 2026.
- The 5-year median for Times Interest Earned is -$12.14 (2025), against an average of -$12.26.
- Across the five-year window, Times Interest Earned slumped 6947.81% in 2024 and jumped 150.01% in 2025, its largest moves.
- Cumberland Pharmaceuticals' Times Interest Earned stood at -$12.69 in 2022, then slumped by 172.29% to -$34.56 in 2023, then jumped by 76.13% to -$8.25 in 2024, then tumbled by 47.15% to -$12.14 in 2025, then slumped by 200.27% to -$36.46 in 2026.
- The last three Times Interest Earned figures came in at -$36.46 (Q1 2026), -$12.14 (Q4 2025), and -$17.92 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 13.44 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 108.60 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 5.39 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -2.31 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 16.72 |
| 10 | Cumberland Pharmaceuticals | 86.62 Mn | 75.28 Mn | 7.20 Mn | -36.46 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -36.46 |
| Dec 31, 2025 | -12.14 |
| Sep 30, 2025 | -17.92 |
| Jun 30, 2025 | -6.82 |
| Mar 31, 2025 | 7.89 |
| Dec 31, 2024 | -8.25 |
| Sep 30, 2024 | -12.33 |
| Jun 30, 2024 | -8.13 |
| Mar 31, 2024 | -15.77 |
| Dec 31, 2023 | -34.56 |
| Sep 30, 2023 | -16.96 |
| Jun 30, 2023 | 0.12 |
| Mar 31, 2023 | -8.22 |
| Dec 31, 2022 | -12.69 |
| Sep 30, 2022 | -1.93 |
| Jun 30, 2022 | -13.42 |
| Mar 31, 2022 | -10.80 |
| Dec 31, 2021 | -156.99 |
| Sep 30, 2021 | -78.09 |
| Jun 30, 2021 | -55.52 |